retatrutide clinical trials weight loss retatrutide (“reta”) is an experimental weight-loss drug currently in Phase 3 trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works Triple hormone receptor agonist retatrutide

One prescription, multiple diseases, and a cascade of transformative outcomes for the industry

"Miami club apologizes after influencers chant Nazi slogans"

Tirzepatide (Zepbound) lists alopecia as an adverse reaction in FDA labeling, while semaglutide (Wegovy, Ozempic) does not

Many people find they naturally eat smaller portions, feel satisfied with less food, experience less emotional eating, and have better control around snacks and desserts

Photos two weeks apart often reveal what daily mirror checks miss entirely

For many, GLP-1 therapy serves as an entry point to weight management or a preparatory phase before surgery